K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions.
about
Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNAEmerging concepts in pancreatic cancer medicine: targeting the tumor stromaGenetic abnormalities in pancreatic cancerRLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancerEffects of a histone deacetylase inhibitor, sodium butyrate, on 53-kDa protein expression and sensitivity to anticancer drugs of pancreatic cancer cellsGlycogen synthase kinase-3 inhibition sensitizes pancreatic cancer cells to TRAIL-induced apoptosisGene expression profile analysis of pancreatic cancer based on microarray data.Pathology and molecular genetics of pancreatic neoplasms.Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung.Clinical significance of serum p53 antigen in patients with pancreatic carcinomasPancreatic adenocarcinoma: epidemiology and genetics.Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer.Epigenetic changes associated with neoplasms of the exocrine and endocrine pancreas.The complex landscape of pancreatic cancer metabolismMolecular analysis of pancreatic acinar cell cystadenomas: Evidence of a non-neoplastic nature.Precursor lesions of pancreatic cancer.Genetic progression in the pancreatic ducts.Therapeutic options for the management of pancreatic cancer.Immature truncated O-glycophenotype of cancer directly induces oncogenic featuresGenetics and pathology of pancreatic cancer.Systemic therapy for metastatic pancreatic adenocarcinoma.Pathological and molecular evaluation of pancreatic neoplasms.Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinomaAcinar Cell Carcinoma of the Pancreas: Overview of Clinicopathologic Features and Insights into the Molecular Pathology.Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinomaThe structural basis of molecular genetic deletions. An integration of classical cytogenetic and molecular analyses in pancreatic adenocarcinoma.Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway.Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutationsCharacterization of Mouse Models of Early Pancreatic Lesions Induced by Alcohol and Chronic PancreatitisRational combination of MEK inhibitor and the STAT3 pathway modulator for the therapy in K-Ras mutated pancreatic and colon cancer cells.Clinical significance of the integrin α6β4 in human malignancies.Identification of disease-associated pathways in pancreatic cancer by integrating genome-wide association study and gene expression data.Telomerase activity, P53 mutation and Ki-ras codon 12 point mutation of the peripheral blood in patients with hepato pancreato biliary diseases.CDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosis.Advances in biomarker research for pancreatic cancer.p53 protein expression and CA19.9 values in differential cytological diagnosis of pancreatic cancer complicated with chronic pancreatitis and chronic pancreatitisRAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies.Prognostic significance of Ki-67 antigen and p53 protein expression in pancreatic duct carcinoma: a study of the monoclonal antibodies MIB-1 and DO-7 in formalin-fixed paraffin-embedded tumour material.Nuclear accumulation of p53 correlates significantly with clinical features and inversely with the expression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) in pancreatic cancerExpression of Ki-67, p53, and K-ras in chronic pancreatitis and pancreatic ductal adenocarcinoma
P2860
Q24568308-9A830BB6-334B-4D8D-871C-53D15A97F2B2Q24627664-7DDFF7AD-3BC3-424A-807D-9DD51DD6AABEQ24800194-246F8873-96CA-4C2E-B90D-9B51DE3BCE9EQ28482104-083EB9AB-59F0-4CD3-9589-51B8635BCF64Q28541586-EB0B398C-A9F9-40F2-8045-B655B982EFC3Q28729017-C830735B-9371-4FC7-8062-A49318BCCA1EQ31066570-73920C8C-243D-42AC-AF60-2ACD55853126Q33581119-5A8D96C0-C03D-4733-A279-15D76BB6EED2Q33606248-FFEB2E3E-EB41-46F7-95C7-709C52BD12A6Q33618106-83E18EB8-1479-4B2B-8642-A045C3C6C9B9Q33677968-9BDDED33-AD5C-46F9-9319-A42CB4B88E04Q33699291-3661E582-E5BB-42F8-8972-D6641D03A8EBQ33771064-C967E598-A6F2-41B7-95C7-DF3C4C4692D0Q33827703-B7E82F1A-7993-4614-9088-C8E008F506ADQ33844265-3491D590-BC7A-4E48-93C6-6C2102625669Q33855814-587906D2-D0A5-4F03-B619-1ECFD94B322EQ33943167-7565D2D2-8B82-40D1-AE25-5C6DB68EA218Q34093776-E26C1272-54EB-4165-B66F-83A9D26ACBF5Q34314283-BC0066B2-A897-4F42-899E-FA17C61DA248Q34589293-BB1401FC-EBE9-4F91-8B3F-4B02686B8AF9Q35076238-4D708529-B431-4501-AB47-9095721AF6A7Q35670143-7D24D615-8B2D-48C5-A796-748720E2E409Q35745947-7D2EB2DB-6BD5-4D19-8B79-7DA07C9B9E4FQ35747259-26625B04-8515-44CD-A19B-29E60D146457Q35753107-E52CD840-CCFB-4ED9-AE80-33033AA3334DQ35764659-BFBC426B-59AC-4D81-B829-C912459B29BAQ35788845-B9845A57-744B-48AD-9516-B005E7E611A7Q35788942-290A1288-9E1B-4B28-8A84-3B52B9594BF5Q35855055-35CD587C-F7AF-4EF6-9EBB-D1F7F8F52B70Q35987390-AEFA7E36-B7E3-4D7A-AA51-42DE2C061B9DQ36010634-6F79A807-6F37-4B87-935C-AEEA04E73378Q36062094-973348C5-5C00-4EF4-818A-527752617ACCQ36063099-0C8936D1-6DAE-4C3B-BC53-B3526A3CB6D5Q36084097-CB8F517C-13EA-4CFE-B26F-5932794046D2Q36126609-8B8DAF79-A417-4675-BB97-A172DE688FB7Q36178952-B2B38BBC-0EC6-480B-BA5C-75BECD853CE6Q36398735-E3015D66-CE4F-44FF-96CF-884D016BC730Q36422395-EFDB867B-8793-4D42-89E3-7BCF7D572B09Q36423050-07DC3FB3-DE75-4FEF-B8F4-1110A58A0358Q36496683-C34BFBB4-3229-40AB-A4B1-AAE7A894D726
P2860
K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions.
description
1994 nî lūn-bûn
@nan
1994 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մարտին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
name
K-ras and p53 gene mutations i ...... ugh different genetic lesions.
@ast
K-ras and p53 gene mutations i ...... ugh different genetic lesions.
@en
K-ras and p53 gene mutations i ...... ugh different genetic lesions.
@nl
type
label
K-ras and p53 gene mutations i ...... ugh different genetic lesions.
@ast
K-ras and p53 gene mutations i ...... ugh different genetic lesions.
@en
K-ras and p53 gene mutations i ...... ugh different genetic lesions.
@nl
prefLabel
K-ras and p53 gene mutations i ...... ugh different genetic lesions.
@ast
K-ras and p53 gene mutations i ...... ugh different genetic lesions.
@en
K-ras and p53 gene mutations i ...... ugh different genetic lesions.
@nl
P2093
P1433
P1476
K-ras and p53 gene mutations i ...... ough different genetic lesions
@en
P2093
Pellegata NS
Ranzani GN
P304
P407
P577
1994-03-01T00:00:00Z